Glass House BrandsGLAS 44 12-1 Month Momentum % is 83.91% as of Jul. 01, 2026. GuruFocus rates GLAS with a GF Score™ of 44/100 and a GF Value™ of $6.46 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 1,018 Drug Manufacturers companies, Glass House Brands ranks better than 92.63% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-07-01), Glass House Brands's 12-1 Month Momentum % is 83.91%.
The industry rank for Glass House Brands's 12-1 Month Momentum % or its related term are showing as below:
GLAS's 12-1 Month Momentum % is ranked better than 92.63% of 1018
companies
in the Drug Manufacturers industry
Industry Median: -6.85
vs GLAS: 83.91
Glass House Brands (NYSE:GLAS) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Glass House Brands 12-1 Month Momentum % Related Terms
GLAS vs ZTS, UTHR: 12-1 Month Momentum % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Glass House Brands's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glass House Brands 12-1 Month Momentum % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Glass House Brands's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Glass House Brands's 12-1 Month Momentum % falls into.
Glass House Brands (NYSE:GLAS) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glass House Brands (GLAS) has a 12-1 Month Momentum % of 83.91% as of Jul. 01, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Glass House Brands and its competitors. According to the industry distribution chart, Glass House Brands ranks #75 out of 1018 companies in the Drug Manufacturers industry, placing it in the top 7.4%.
Is Glass House Brands' 12-1 Month Momentum % too high?
Glass House Brands' current 12-1 Month Momentum % is 83.91%. Based on the distribution chart, Glass House Brands ranks #75 out of 1018 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Glass House Brands has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Glass House Brands' 12-1 Month Momentum % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Glass House Brands ranks #75 out of 1018 companies for 12-1 Month Momentum %. This places Glass House Brands in the top 7% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Drug Manufacturers company?
A good 12-1 Month Momentum % depends on the Drug Manufacturers industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Glass House Brands and its competitors. Glass House Brands's current 12-1 Month Momentum % is 83.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glass House Brands stock overvalued right now?
Based on GuruFocus' analysis, Glass House Brands (GLAS) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.46, compared to a current price of $13.00 — trading 101.2% above its estimated fair value. The current 12-1 Month Momentum % is 83.91%. Glass House Brands' overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Glass House Brands (GLAS), the current 12-1 Month Momentum % is 83.91% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Glass House Brands (GLAS) Overvalued in 2026?
Based on GuruFocus' analysis, Glass House Brands stock appears to be overvalued.
The current stock price of $13.00 is trading 101.2% above its estimated GF Value™ of $6.46.
GuruFocus considers Glass House Brands to be Significantly Overvalued.
Key valuation signals for GLAS:
12-1 Month Momentum %: 83.91%
GF Value™: $6.46 vs. price of $13.00 (101.2% above fair value)
No single metric tells the full story. See the GLAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.
44GF Score
Get the complete analysis for GLAS
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLAS has been successfully added to your 